Bluecrux plans to integrate the Irish startup’s workflow flow management tool with the existing product.
PlanDomino, a productivity management software tool for labs, was acquired by Belgian company Bluecrux.
The Galway startup already has developed a software platform to help pharmaceutical companies manage the complex workflows they handle every day in labs and to reduce operating costs.
Bluecrux develops Binocs, a software-as-a-service product for lab management and scheduling used by more than 1,000 teams. Under the terms of the acquisition, PlanDomino is merging with Binocs. No financial terms have been revealed.
Greg Heaslip, chief executive of PlanDomino, founded the company in 2017 after previously working as a consultant in the life sciences sector and noted some of the operational challenges faced by labs.
“Joining the Binocs team pushes the fast-forward button for our business. By joining forces and bringing together software engineering teams, we will be able to quickly deliver our ‘lab- of-the-future ‘, ”Heaslip said.
The Galway -based startup has raised little funding so far, including € 30,000 from the Portcase of investors in the Portershed of the NDRC and some funding from the European Innovation Council. It was fulfilled a number of pilots with labs.
“PlanDomino brings greater experience and knowledge and will support our further growth and geographic expansion,” said Geert Vanhove, executive vice-president of Binocs. “Moreover, both PlanDomino and Binocs have great enhancements and changes presented, which can be combined into one roadmap.”
Koen Jaspers, chief executive of Bluecrux, added that the Irish start -up “perfectly fits our further growth strategy”.
“It strengthens our leadership position in changing the life sciences. And with our headquarters in Belgium, our office in New Jersey and now a new office in Ireland, we are very excited to create a third hub to host of the best talent, ”Jaspers said.
Disclaimer: The opinions expressed within this article are the personal opinions of the author. The facts and opinions appearing in the article do not reflect the views of knews.uk and knews.uk does not assume any responsibility or liability for the same.